Fri, March 19, 2021
Thu, March 18, 2021
Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021
Thu, March 11, 2021
Wed, March 10, 2021
Tue, March 9, 2021
Mon, March 8, 2021

Michelle Gilson Maintained (ASND) at Strong Buy with Increased Target to $190 on, Mar 12th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-190-on-mar-12th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michelle Gilson of Canaccord Genuity, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $172 to $190 on, Mar 12th, 2021.

Michelle has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Michelle's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Michelle


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $176 on, Thursday, March 11th, 2021
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $199 on, Friday, November 13th, 2020
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $191 on, Thursday, November 12th, 2020

Publication Contributing Sources